How to Use SEC-HPLC for Protein Purity and Homogeneity Analysis?

In biopharmaceuticals and life sciences research, the purity and homogeneity of proteins are critical quality attributes (CQA) that directly affect the safety, efficacy, and stability of biological products. Size Exclusion High-Performance Liquid Chromatography (SEC-HPLC), with its high resolution, mild separation, and quantitative capabilities, has become a core technology for analyzing protein purity and aggregation state. This article introduces the principles, operational essentials, key parameters, and methods for data interpretation of SEC-HPLC.

 

1. Principles and Advantages of SEC-HPLC

SEC-HPLC (Size Exclusion Chromatography-High Performance Liquid Chromatography) separates based on molecular size. The chromatography column is filled with porous silica or polymer gel materials, and protein molecules are separated by the 'sieving effect' as they enter or exclude the pores in the mobile phase, based on molecular size. Large molecules elute quickly as they cannot enter the pores, while smaller molecules are delayed.

Main advantages include:

• High resolution and good reproducibility: capable of distinguishing protein monomers, oligomers, and aggregates;

• Mild separation conditions: non-denaturing separation to maintain protein structure and activity;

• Outstanding quantitative ability: detectors like UV absorption can achieve quantitative analysis of components;

• Wide applicability: covers various biological products such as monoclonal antibodies, vaccines, recombinant proteins, enzymes, etc.

 

2. Sample Preparation and System Optimization

1. Sample Preparation

To ensure column efficiency and data accuracy, samples must be rigorously pre-treated:

• Use a 0.22 µm filter to remove particulate impurities and avoid column bed blockage;

• Buffer solution should match the mobile phase to maintain protein stability and avoid baseline drift or peak distortion due to different buffers;

• Control sample concentration; too high may lead to column overload and peak broadening, too low results in insufficient signal.

 

2. Chromatography Column and Mobile Phase

Select SEC chromatography columns with appropriate pore size (e.g., 300 Å or higher) and particle size (3–5 µm) to ensure the separation of protein monomers and aggregates. The mobile phase often uses physiological salt concentrations (e.g., 150 mM NaCl) and neutral buffers (e.g., phosphate buffer) to reduce nonspecific adsorption and maintain protein conformation. Optimize flow rate (usually 0.2–0.5 mL/min) to balance resolution and analysis time.

 

3. System Validation

System suitability validation should be conducted before SEC-HPLC analysis, including:

• Column efficiency (theoretical plate number);

• Retention time reproducibility (RSD<1%);

• Peak area linear range;

• Accuracy of molecular weight calibration curve (not involving specific standards brands).

 

3. Detection and Data Analysis

Common detectors include UV detectors (UV), generally set at a detection wavelength of 280 nm, suitable for the absorption characteristics of protein aromatic residues. For complex samples, multi-angle light scattering (MALS) and refractive index (RI) detection can be introduced to obtain molecular weight distribution and concentration information.

Key indicators for data interpretation include:

• Purity assessment: the percentage of the main peak area over the total peak area, reflecting protein purity;

• Homogeneity analysis: examining monomer peak symmetry, full width at half maximum (FWHM), and stability of retention time;

• Aggregate detection: early elution peaks (large volume) indicate high molecular aggregate content;

• Degradation product identification: late elution peaks (small volume) may indicate low molecular degradation products;

• Molecular weight confirmation: using molecular weight calibration curves to estimate the molecular weight of each component, validating homogeneity combined with MALS detection results.

 

4. Application Value of SEC-HPLC in Biopharmaceuticals

SEC-HPLC plays a crucial role in multiple stages of biopharmaceutical development:

• Drug development: monitoring purity and aggregate content during recombinant protein and monoclonal antibody preparation;

• Process development: optimizing upstream expression and downstream purification processes to ensure the final product quality;

• Quality control: serving as an important means for release and stability testing, evaluating batch consistency and long-term stability;

• Regulatory compliance: conforming to international quality standards such as ICH Q6B, supporting registration and submission documentation.

 

Due to its mild, high-resolution, and quantitative capabilities, SEC-HPLC has become a core technology for analyzing protein purity and homogeneity. Through reasonable sample preparation, system optimization, and data interpretation, it can comprehensively evaluate protein quality attributes, identify aggregates and degradation products, ensuring product safety and efficacy. Biotech Park Biology Technology, relying on an advanced SEC-HPLC platform and an experienced analytical team, offers one-stop solutions from method development, system validation to sample analysis. Our services cover various biological drugs and complex protein products, ensuring results with high resolution, good reproducibility, and comparability, meeting multi-level needs from research and development to production quality control.

 

Biotech Park Biology Technology — Characterization of Biological Products, a High-Quality Service Provider for Multi-Group Biomass Spectrometry Detection

 

Related services:

HPLC determination of protein purity